Staying Hopeful: Treatment Burnout in Chronic Disease
You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!
Key Questions
- What causes treatment failure — when a treatment fails us?
- Why do we have to try the older, less effective therapies before new medications will be paid for by our insurance?
- What is the American Headache Society Consensus Statement on new therapies for migraine?
- What is self-stigma?
- What is learned helplessness and how does it apply to migraine?
- How is learned helplessness tied to depression and anxiety?
- How can we become more resilient?
- What is the PERMA model of well-being?
- How can we stay hopeful?
- Are we born with resilience, or can we cultivate it?
- What are the five behavioral therapies with evidence for migraine prevention and migraine management?
- What is the best way to get started with behavioral therapies?
- What is interictal anxiety or anticipatory anxiety?
- Why is it so meaningful to ask for and accept help?
- What are some ways to show compassion to ourselves?
Interview Notes
Find more about Dawn Buse, PhD and her work here:
- dawnbuse.com (Resources tab)
- PubMed
- The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice
Treatments Mentioned
- Acceptance and commitment therapy (ACT)
- Biofeedback
- Cognitive Behavioral Therapy (CBT)
- Mindfulness-based cognitive therapy (MBCT)
- Mindfulness therapies
- Neurostimulation
- Relaxation therapy
- Relaxation training
- SEEDS
Please note: The Migraine World Summit’s aim is to bring you a variety of perspectives and expertise, independent of bias or judgment. Alternative theories presented in this video have not been medically reviewed. Views expressed in this interview do not necessarily represent the views of the Migraine World Summit. Please always consult your health care professional and do your own research before making changes to your treatment plan.
Dawn C. Buse, PhD
Psychologist & Clinical Professor
Albert Einstein College of Medicine
Dawn C. Buse, PhD, is a clinical professor of neurology at Albert Einstein College of Medicine. She is a member of the board of directors of the Headache Cooperative of the Pacific, and a licensed psychologist. She has authored more than 200 scientific manuscripts and has won eight U.S. and international research awards and six professional awards for her work in the field of migraine.
She is a co-investigator on numerous U.S. and international studies, including the American Migraine Prevalence and Prevention (AMPP) study; the Chronic Migraine Epidemiology and Outcomes (CaMEO) study; the Migraine Signature Study (MSS); the International Burden of Migraine Study (IBMS); the Migraine in America Symptoms and Treatment (MAST) study; the Observational Survey of the Epidemiology, Treatment and Care of Migraine (OVERCOME) study; and a recipient of the FDA-sponsored Migraine Clinical Outcome Assessment System (MiCOAS) grant, which is gathering patient input for the development of migraine clinical trial endpoints. She is an advocate for the well-being of patients and healthcare professionals.
Interviews from Dawn C. Buse, PhD
Brain-Related Comorbidities of Migraine
How Migraine Affects Our Mental Health
Staying Hopeful: Treatment Burnout in Chronic Disease
Cultivating Resilience and Strength Through Migraine
How Depression Affects Your Mood: Anxiety & Depression
Is Your Family Time Affected by Migraine?
Behavioral Approaches / Impact of Childhood Abuse
Purchase full access to the entire 2024 Summit to unlock:
- All expert interviews with separate audio (MP3) files & transcripts
- 30 extended, uncut interview editions with hours more expert footage
- Lifetime on-demand access with no annual fee to 2024 Summit
- Interview Summaries
- Treatment Directory & Guidelines
- And much more!
Related Talks for: Day 8 (2022)
How Women’s Hormones Affect Migraine
Jelena Pavlović, MD, PhD
The Latest Cannabis Research for Migraine
Nathaniel M. Schuster, MD
The Latest Developments in Migraine Research
Richard B. Lipton, MD
We support research for better treatments and a cure while advocating to improve the lives of those struggling with cluster headaches.
The VIP Treatment Directory lists over 300 options including treatments, therapies, devices, procedures, strategies and approaches to treat or prevent migraine. Only available with the VIP Access Pass. Learn more at the order page.
